Fortrea Holdings Inc.
Closed
SectorHealthcare
13.17 -3.73
Overview
Share price change
24h
Min
13.14
Max
13.48
Income | 8.9M -24M |
|---|---|
Sales | -24M 637M |
EPS | 0.16 |
Profit margin | -3.708 |
Employees | 14,000 |
EBITDA | 16M 23M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +13.72% upside |
Next Earnings | 5 sie 2026 |
|---|
Market Cap | 127M 1.3B |
|---|---|
Previous open | 16.9 |
Previous close | 13.17 |
Fortrea Holdings Inc. Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Fortrea Holdings Inc. Forecast
Price Target
By TipRanks
13.72% upside
12 Months Forecast
Average 15.58 USD 13.72%
High 20 USD
Low 9.5 USD
Based on 10 Wall Street analysts offering 12 month price targets forFortrea Holdings Inc. - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Fortrea Holdings Inc.
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
